Jack Hsiao
Direktor/Vorstandsmitglied bei APPLIED BIOCODE CORPORATION
Aktive Positionen von Jack Hsiao
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
APPLIED BIOCODE CORPORATION | Direktor/Vorstandsmitglied | 03.01.2018 | - |
Independent Dir/Board Member | 03.01.2018 | - | |
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - |
Karriereverlauf von Jack Hsiao
Statistik
International
Vereinigte Staaten | 2 |
Taiwan | 2 |
Operativ
Director/Board Member | 2 |
Independent Dir/Board Member | 2 |
Sektoral
Electronic Technology | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
APPLIED BIOCODE CORPORATION | Health Technology |
Private Unternehmen | 1 |
---|---|
Applied BioCode, Inc.
Applied BioCode, Inc. Electronic Equipment/InstrumentsElectronic Technology Part of Applied BioCode Corp., Applied BioCode, Inc. is a diagnostic testing company that designs, develops, and commercializes multiplex testing products. The company is based in Santa Fe Springs, CA. Applied BioCode offers a range of diagnostic assays, including the BioCode SARS-CoV-2 assay, the BioCode Respiratory Pathogen Panel, and the BioCode Gastrointestinal Pathogen Panel. The company's technology combines "digital barcodes" with immuno- and molecular chemistry to create a new, bio-inspired Barcoded Magnetic Beads (BMB) technology. The micro BMBs are about the diameter of a human hair and are the ideal choice for cost-effective high throughput syndromic panels. The company was founded in 2008 by Winston Z. Ho, and Christopher M. Bernard has been the CEO of the company since 2022. | Electronic Technology |
- Börse
- Insiders
- Jack Hsiao
- Erfahrung